These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38506312)

  • 1. Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study.
    Lopez-Medina AI; Campos-Staffico AM; A Chahal CA; Volkers I; Jacoby JP; Berenfeld O; Luzum JA
    Pharmacogenomics; 2024 Feb; 25(3):117-131. PubMed ID: 38506312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome.
    Weeke P; Mosley JD; Hanna D; Delaney JT; Shaffer C; Wells QS; Van Driest S; Karnes JH; Ingram C; Guo Y; Shyr Y; Norris K; Kannankeril PJ; Ramirez AH; Smith JD; Mardis ER; Nickerson D; George AL; Roden DM
    J Am Coll Cardiol; 2014 Apr; 63(14):1430-7. PubMed ID: 24561134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes.
    Kääb S; Crawford DC; Sinner MF; Behr ER; Kannankeril PJ; Wilde AA; Bezzina CR; Schulze-Bahr E; Guicheney P; Bishopric NH; Myerburg RJ; Schott JJ; Pfeufer A; Beckmann BM; Martens E; Zhang T; Stallmeyer B; Zumhagen S; Denjoy I; Bardai A; Van Gelder IC; Jamshidi Y; Dalageorgou C; Marshall V; Jeffery S; Shakir S; Camm AJ; Steinbeck G; Perz S; Lichtner P; Meitinger T; Peters A; Wichmann HE; Ingram C; Bradford Y; Carter S; Norris K; Ritchie MD; George AL; Roden DM
    Circ Cardiovasc Genet; 2012 Feb; 5(1):91-9. PubMed ID: 22100668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants.
    Lopez-Medina AI; Chahal CAA; Luzum JA
    Pharmacogenomics; 2022 Jun; 23(9):543-557. PubMed ID: 35698903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome.
    Nishio Y; Makiyama T; Itoh H; Sakaguchi T; Ohno S; Gong YZ; Yamamoto S; Ozawa T; Ding WG; Toyoda F; Kawamura M; Akao M; Matsuura H; Kimura T; Kita T; Horie M
    J Am Coll Cardiol; 2009 Aug; 54(9):812-9. PubMed ID: 19695459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Patient-Specific p.D85N-Potassium Voltage-Gated Channel Subfamily E Member 1-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Model for Drug-Induced Long QT Syndrome.
    Kim M; Ye D; John Kim CS; Zhou W; Tester DJ; Giudicessi JR; Ackerman MJ
    Circ Genom Precis Med; 2021 Jun; 14(3):e003234. PubMed ID: 34003017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KCNE1 D85N polymorphism--a sex-specific modifier in type 1 long QT syndrome?
    Lahtinen AM; Marjamaa A; Swan H; Kontula K
    BMC Med Genet; 2011 Jan; 12():11. PubMed ID: 21244686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.
    Paulussen AD; Gilissen RA; Armstrong M; Doevendans PA; Verhasselt P; Smeets HJ; Schulze-Bahr E; Haverkamp W; Breithardt G; Cohen N; Aerssens J
    J Mol Med (Berl); 2004 Mar; 82(3):182-8. PubMed ID: 14760488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Instability of KCNE1-D85N that causes long QT syndrome: stabilization by verapamil.
    Sakata S; Kurata Y; Li P; Notsu T; Morikawa K; Miake J; Higaki K; Yamamoto Y; Yoshida A; Shirayoshi Y; Yamamoto K; Horie M; Ninomiya H; Kanzaki S; Hisatome I
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):853-63. PubMed ID: 24499369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced QT-interval prolongation and recurrent torsade de pointes in a child with heterotaxy syndrome and KCNE1 D85N polymorphism.
    Lin L; Horigome H; Nishigami N; Ohno S; Horie M; Sumazaki R
    J Electrocardiol; 2012; 45(6):770-3. PubMed ID: 22999324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polygenic risk score for the QT interval is an independent predictor of drug-induced QT prolongation.
    Simon ST; Lin M; Trinkley KE; Aleong R; Rafaels N; Crooks KR; Reiter MJ; Gignoux CR; Rosenberg MA
    PLoS One; 2024; 19(6):e0303261. PubMed ID: 38885227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of propofol sensitivity of cardiac I
    Kojima A; Mi X; Fukushima Y; Ding WG; Omatsu-Kanbe M; Matsuura H
    Br J Pharmacol; 2021 Jul; 178(13):2690-2708. PubMed ID: 33763865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin, a dietary natural supplement, prolongs the action potential duration of KCNE1-D85N-induced pluripotent stem cell-derived cardiomyocytes.
    Martinez K; Smith A; Ye D; Zhou W; Tester DJ; Ackerman MJ
    Heart Rhythm; 2023 Apr; 20(4):580-586. PubMed ID: 36586707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common candidate gene variants are associated with QT interval duration in the general population.
    Marjamaa A; Newton-Cheh C; Porthan K; Reunanen A; Lahermo P; Väänänen H; Jula A; Karanko H; Swan H; Toivonen L; Nieminen MS; Viitasalo M; Peltonen L; Oikarinen L; Palotie A; Kontula K; Salomaa V
    J Intern Med; 2009 Apr; 265(4):448-58. PubMed ID: 19019189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LQT5 masquerading as LQT2: a dominant negative effect of KCNE1-D85N rare polymorphism on KCNH2 current.
    Nof E; Barajas-Martinez H; Eldar M; Urrutia J; Caceres G; Rosenfeld G; Bar-Lev D; Feinberg M; Burashnikov E; Casis O; Hu D; Glikson M; Antzelevitch C
    Europace; 2011 Oct; 13(10):1478-83. PubMed ID: 21712262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation screening in KCNQ1, HERG, KCNE1, KCNE2 and SCN5A genes in a long QT syndrome family.
    Koo SH; Teo WS; Ching CK; Chan SH; Lee EJ
    Ann Acad Med Singap; 2007 Jun; 36(6):394-8. PubMed ID: 17597962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes.
    Schwartz PJ; Woosley RL
    J Am Coll Cardiol; 2016 Apr; 67(13):1639-1650. PubMed ID: 27150690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany.
    Sarganas G; Garbe E; Klimpel A; Hering RC; Bronder E; Haverkamp W
    Europace; 2014 Jan; 16(1):101-8. PubMed ID: 23833046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphism map of five long-QT genes.
    Aydin A; Bähring S; Dahm S; Guenther UP; Uhlmann R; Busjahn A; Luft FC
    J Mol Med (Berl); 2005 Feb; 83(2):159-65. PubMed ID: 15599693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long QT syndrome type 5-Lite: Defining the clinical phenotype associated with the potentially proarrhythmic p.Asp85Asn-KCNE1 common genetic variant.
    Lane CM; Giudicessi JR; Ye D; Tester DJ; Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2018 Aug; 15(8):1223-1230. PubMed ID: 29625280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.